TipHub

793.8

+9.88 +1.26%

As of 27 Jul 2026 · delayed

NSE Listed

Anthem Biosciences Ltd. (ANTHEM)

Volume: 5,27,898Avg Vol 1W: 12,67,171.6Avg Vol 1M: 8,23,705.152W Range:579.15873.5
Key Ratios
Checked 1d ago
Market Cap₹43,360 Cr
Current Price₹793.8
Previous Close₹783.92
High / Low (52w)₹873.5 / ₹579.15
Volume5,27,898
Avg Vol (1W)12,67,171.6
Avg Vol (1M)8,23,705.1
Stock P/E0
Book Value₹43.1
Dividend Yield
ROE20.8%
ROA
Revenue (TTM)₹1,930 Cr
Revenue Growth
Profit Margin
Total Debt₹47 Cr
Shares Outstanding
Face Value₹2
EPS (TTM)₹8.07
P/B0
Debt / Equity0.08
50 DMA₹767.73
200 DMA₹705.01
Day change+1.26%
Price Chart
793.8 1.45% · 1Y
8655881.1Cr
2025-07-29
2026-07-27

20-day avg volume: 8.2L shares

Pros
  • Healthy return on equity of 20.8%.
  • Company is almost debt-free.
Cons
  • Revenue fell 43% YoY.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹525 Cr₹498 Cr₹483 Cr₹540 Cr₹550 Cr₹423 Cr₹611 Cr₹418 Cr
EBITDA₹203 Cr₹164 Cr₹179 Cr₹188 Cr₹233 Cr₹156 Cr₹279 Cr₹145 Cr
Net Profit₹162 Cr₹124 Cr₹83 Cr₹136 Cr₹173 Cr₹93 Cr₹190 Cr₹120 Cr
EPS
Profit & Loss (Annual)
MetricMar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026Jun 2026
Revenue₹479 Cr₹1,930 Cr₹538 Cr₹552 Cr₹417 Cr₹583 Cr₹2,280 Cr₹384 Cr
EBITDA₹215 Cr₹667 Cr₹201 Cr₹256 Cr₹176 Cr₹301 Cr₹856 Cr₹137 Cr
Net Profit₹123 Cr₹451 Cr₹148 Cr₹198 Cr₹112 Cr₹212 Cr₹592 Cr₹102 Cr
EPS8.0410.43
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹787 Cr₹1,034 Cr₹1,619 Cr₹2,014 Cr₹2,398 Cr₹2,808 Cr₹3,429 Cr
Total Liabilities₹365 Cr₹332 Cr₹264 Cr₹274 Cr₹473 Cr₹398 Cr₹387 Cr
Equity₹422 Cr₹701 Cr₹1,355 Cr₹1,741 Cr₹1,925 Cr₹2,410 Cr₹3,043 Cr
Total Debt
Cash Flow
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹211 Cr₹348 Cr₹456 Cr₹421 Cr₹260 Cr₹430 Cr₹1,048 Cr
Investing₹-109 Cr₹-196 Cr₹-205 Cr₹-376 Cr₹-221 Cr₹-147 Cr₹-702 Cr
Financing₹-48 Cr₹-63 Cr₹181 Cr₹64 Cr₹-77 Cr₹-136 Cr₹-40 Cr
Free Cash Flow₹211 Cr₹348 Cr₹456 Cr₹421 Cr₹260 Cr₹430 Cr₹1,048 Cr
Shareholding
Promoter 71.42% Institutions 16.05% Public 12.53%
Efficiency & Working Capital
ROCE30.5%
Interest Coverage117.8
Dividend Payout
Debtor Days101 d
Inventory Days21 d
Payable Days13 d
Cash Conversion Cycle110 d
Working Capital Days123 d
Shareholding Details

As of 2026-06-30

Promoter71.4%
FII2.6%
DII13.5%
Institutions16.1%
Public12.5%
Promoter Pledge0%
No. of Shareholders1,73,273
Shareholding Pattern

Quarterly — figures in %. Latest 7 quarters.

PeriodDec 2024Jul 2025Jul 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters77.2%74.7%74.7%74.7%74.7%74.7%71.4%
FIIs0%1.5%1.5%1.7%1.4%1.3%2.6%
DIIs0%3.6%3.6%7.2%7.6%11.5%13.5%
Public22.8%20.2%20.2%16.4%16.3%12.5%12.5%
Promoter Pledge0%0%0%0%0%0%0%
No. of Shareholders168,25,8448,25,8442,17,6811,99,4921,80,2201,73,273
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603
Major Shareholders (>1%)
NameCategoryStakeShares
Ajay BhardwajShareholding of Promoter and Promoter Group42.4%23.89 Cr
Ishaan BhardwajShareholding of Promoter and Promoter Group10.1%5.70 Cr
Ganesh SambasivamShareholding of Promoter and Promoter Group8.1%4.57 Cr
K C RavindraShareholding of Promoter and Promoter Group7.8%4.36 Cr
Portsmouth Technologies LlcPublic Shareholding2.7%1.54 Cr
Hdfc Trustee Company Limited-hdfc Flexi Cap FundPublic Shareholding2.4%1.38 Cr
Malay Jiban BaruaPublic Shareholding2.3%1.27 Cr
Satish S SharmaPublic Shareholding2.3%1.27 Cr
Rupesh Narharrao KinekarPublic Shareholding2.2%1.25 Cr
Sbi Mnc FundPublic Shareholding1.8%98,88,996
Quant Mutual Fund - Quant Mid Cap FundPublic Shareholding1.5%82,88,660
Axis Elss Tax Saver FundPublic Shareholding1.2%66,86,210
S VijayalakshmiShareholding of Promoter and Promoter Group1%57,04,868
Keerthi Trust(trustee Is K C Ravindra)Shareholding of Promoter and Promoter Group1%57,04,868
Swara Trust(trustee Is K C Ravindra)Shareholding of Promoter and Promoter Group1%57,04,868
Anthem Bio Pharma Private LimitedShareholding of Promoter and Promoter Group0%0
Herambaya TrustShareholding of Promoter and Promoter Group0%0
Sumukhaya TrustShareholding of Promoter and Promoter Group0%0
Vira TrustShareholding of Promoter and Promoter Group0%0
Ravisika Hospitality LlpShareholding of Promoter and Promoter Group0%0
Cherrypick InvestorShareholding of Promoter and Promoter Group0%0
Kashmiira NayarShareholding of Promoter and Promoter Group0%0
Raman NayarShareholding of Promoter and Promoter Group0%0
Pramila Raman NayarShareholding of Promoter and Promoter Group0%0
Nischal Rye NayarShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
Ajay BhardwajCMD & Executive Director2026
GANESH SAMBASIVAMWTD & Executive Director2026
K RAVINDRA CHANDRAPPAWTD & Executive Director2026
Satish Chander SubbannaNon Executive Nominee Director2026
Ramesh RamaduraiIndependent Non Exe. Director2026
Ravi UppalIndependent Non Exe. Director2026
Subramanian MadhavanIndependent Non Exe. Director2026
Shubha KulkarniIndependent Non Exe. Director2026
Divya PrasadCompany Sec. & Compli. Officer2026
Segments — Product
SegmentRevenueShare
CRDMO₹1,730 Cr82.8%
Speciality Ingredients₹360 Cr17.2%
Segments — Geography
RegionRevenueShare
North America (USA)₹534 Cr25.6%
Europe₹1,131 Cr54.1%
India₹340 Cr16.3%
Rest of asia and others₹83 Cr4%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹2120112112
Corporate Actions
TypeDateValueRemark
forthcoming2026-07-21Board Meetings
dividend2026-06-25₹2.0 (100.0%)Final
dividend2026-06-25₹2 (100%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2026753002726806
20264450003448
202637003545
Insider / Designated-Person Trades

3 recent disclosure(s)

Krithika GaneshDisposal · 85,57,302
Aruna GaneshAcquisition · 85,57,302
Viridity Tone LLPDisposal · 2,03,13,795
Company Information
Incorporated2006
ChairmanAjay Bhardwaj
AuditorK P Rao & Co/S R Batliboi & Associates LLP
Investor Email[email protected]
🌐 www.anthembio.com

📍 49 F1 & F2 Canara Bank Road, Bommasandra Industrial Area, Bangalore, Karnataka, 560099

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search